Skip to main navigation Top Menu News Events Careers Products Donors Patients Education Investors About Contact Home > Investors Relations > Financial Information > SEC Filings Financial Reports SEC Filings News Releases News Releases Year: - Any - Items per page 10 November 9, 2021 at 4:05 PM EST CryoLife to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics, and Digital Health & Services Forum ATLANTA , Nov. 9, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that members of management will host one-on-one meetings at the upcoming Canaccord Genuity MedTech, Diagnostics, and Digital Health & November 4, 2021 at 4:05 PM EDT CryoLife Reports Third Quarter 2021 Financial Results ATLANTA , Nov. 4, 2021 /PRNewswire/ -- Third Quarter and Recent Business Highlights: Achieved total revenues of $72.2 million in the third quarter 2021 versus $65.1 million in the third quarter of 2020, an increase of 11% on a GAAP basis and 9% on a non-GAAP proforma constant currency basis Net October 20, 2021 at 4:10 PM EDT CryoLife Announces Release Date and Teleconference Call Details for Third Quarter 2021 Financial Results ATLANTA , Oct. 20, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that third quarter 2021 financial results will be released on Thursday, November 4, 2021 after the market closes. September 22, 2021 at 4:25 PM EDT Anthony Semedo Joins CryoLife Board of Directors ATLANTA , Sept. 22, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today the appointment of Anthony "Tony" Semedo to its Board of Directors effective October 1, 2021 . August 31, 2021 at 4:25 PM EDT CryoLife to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference ATLANTA , Aug. 31, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming Morgan Stanley 19 th Annual Global Healthcare Conference on Tuesday, September 14, 2021 . August 2, 2021 at 4:30 PM EDT CryoLife to Participate in Upcoming Virtual Investor Conferences ATLANTA , Aug. 2, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in two upcoming virtual investor conferences. CryoLife's management team will present at the upcoming Canaccord July 29, 2021 at 4:05 PM EDT CryoLife Reports Second Quarter 2021 Financial Results ATLANTA , July 29, 2021 /PRNewswire/ -- Second Quarter and Recent Business Highlights: Achieved total revenues of $76.1 million in the second quarter 2021 versus $53.8 million in the second quarter of 2020, an increase of 42% on a GAAP basis and 35% on a non-GAAP proforma constant currency July 29, 2021 at 8:00 AM EDT CryoLife Announces Sale of PerClot to Baxter ATLANTA , July 29, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has completed the sale of its PerClot product line to a subsidiary of Baxter International, Inc. July 15, 2021 at 4:25 PM EDT CryoLife Announces Release Date and Teleconference Call Details for Second Quarter 2021 Financial Results ATLANTA , July 15, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that second quarter 2021 financial results will be released on Thursday, July 29, 2021 after the market closes. On that day, the Company May 18, 2021 at 8:35 AM EDT CryoLife to Participate in the UBS Global Healthcare Virtual Conference ATLANTA , May 18, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming UBS Global Healthcare Virtual Conference on Tuesday, May 25, 2021 . Pagination Current page 1 Page 2 Page 3 Page 4 … Next page Next Last page Last Displaying 1 - 10 of 624 results Print Page RSS Feeds Email Alerts Contact Information Investor Relations Investor Overview Stock Information Financial Information Webcasts and Presentations Analyst Coverage Corporate Governance Email Alerts Information Request Contact Information CryoLife, Inc. - 1655 Roberts Blvd., Kennesaw, GA 30144, U.S.A | 800.438.8285 Footer Privacy Policy Terms of Use Employees Careers Contact Partners